Docket
117th Congress · HOUSE BILLBILL

H.R. 3927 — MADE in America Act

“To mitigate drug shortages and provide incentives for maintaining, expanding, and relocating the manufacturing of active pharmaceutical ingredients, excipients, medical diagnostic devices, pharmaceuticals, and personal protective equipment in the United States, and for other purposes.”

Health
Introduced Jun 16, 2021
Last action Jun 17, 2021
Pipeline · Bill → Law
Step 1
Introduced
Jun 16, 2021
Step 2
Referred
Jun 17, 2021
E&C · Ways & Means
Step 3
Committee
Step 4
House floor
Step 5
Senate
Step 6
Resolve Changes
Step 7
Signed
SummaryNo summary available

No CRS summary available for this bill.

Provisions · 8 sectionsIntroduced in House
5 provisions
1 provision
Timeline · 4 actions
Jun 17, 2021
Referred to the Subcommittee on Health.
Jun 16, 2021
Introduced in House
Jun 16, 2021
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Jun 16, 2021
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.